{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T03:10:09Z","timestamp":1789441809287,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T00:00:00Z","timestamp":1659139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T00:00:00Z","timestamp":1659139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100006400","name":"Alnylam Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006400","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s12325-022-02172-8","type":"journal-article","created":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T15:02:26Z","timestamp":1659193346000},"page":"4330-4345","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Patient Perspective on Acute Hepatic Porphyria with Sporadic Attacks: A Chronic Disease with Substantial Health-Related Quality of Life Impacts"],"prefix":"10.1007","volume":"39","author":[{"given":"Kristen","family":"Wheeden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desiree","family":"Lyon Howe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Burrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liz","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Chamberlayne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edrin R.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordanna","family":"Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie","family":"Paulich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Meninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5020-6627","authenticated-orcid":false,"given":"Stephen","family":"Lombardelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,30]]},"reference":[{"issue":"2","key":"2172_CR1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/hep4.1297","volume":"3","author":"B Wang","year":"2019","unstructured":"Wang B, Rudnick S, Cengia B, Bonkovsky HL. Acute hepatic porphyrias: review and recent progress. Hepatol Commun. 2019;3(2):193\u2013206.","journal-title":"Hepatol Commun"},{"key":"2172_CR2","doi-asserted-by":"crossref","unstructured":"De Souza PVS, de Mattos Lombardi Badia B, Farias IB, Gon\u00e7alves EA, de Rezende Pinto WBV, Oliveira ASB. Acute hepatic porphyrias for the neurologist: current concepts and perspectives. Arq Neuropsiquiatr. 2021;79(1):68\u201380.","DOI":"10.1590\/0004-282x20200096"},{"issue":"9718","key":"2172_CR3","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/S0140-6736(09)61925-5","volume":"375","author":"H Puy","year":"2010","unstructured":"Puy H, Gouya L, Deybach JC. Porphyrias. Lancet. 2010;375(9718):924\u201337.","journal-title":"Lancet"},{"issue":"12","key":"2172_CR4","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1016\/j.amjmed.2014.06.036","volume":"127","author":"HL Bonkovsky","year":"2014","unstructured":"Bonkovsky HL, Maddukuri VC, Yazici C, et al. Acute porphyrias in the USA: features of 108 subjects from porphyrias consortium. Am J Med. 2014;127(12):1233\u201341.","journal-title":"Am J Med"},{"issue":"5","key":"2172_CR5","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1532\/IJH97.03127","volume":"79","author":"M Kondo","year":"2004","unstructured":"Kondo M, Yano Y, Shirataka M, Urata G, Sassa S. Porphyrias in Japan: compilation of all cases reported through 2002. Int J Hematol. 2004;79(5):448\u201356.","journal-title":"Int J Hematol"},{"key":"2172_CR6","unstructured":"Kothadia JP, LaFreniere K, Shah JM. Acute hepatic porphyria. Treasure Island: StatPearls; 2021."},{"issue":"6","key":"2172_CR7","doi-asserted-by":"publisher","first-page":"439","DOI":"10.7326\/0003-4819-142-6-200503150-00010","volume":"142","author":"KE Anderson","year":"2005","unstructured":"Anderson KE, Bloomer JR, Bonkovsky HL, et al. Recommendations for the diagnosis and treatment of the acute porphyrias. Ann Intern Med. 2005;142(6):439\u201350.","journal-title":"Ann Intern Med"},{"issue":"3","key":"2172_CR8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ymgme.2019.03.002","volume":"128","author":"HL Bonkovsky","year":"2019","unstructured":"Bonkovsky HL, Dixon N, Rudnick S. Pathogenesis and clinical features of the acute hepatic porphyrias (AHPs). Mol Genet Metab. 2019;128(3):213\u20138.","journal-title":"Mol Genet Metab"},{"key":"2172_CR9","doi-asserted-by":"crossref","unstructured":"Pischik E, Kauppinen R. An update of clinical management of acute intermittent porphyria. Appl Clin Genet. 2015;8:201\u201314. https:\/\/www.dovepress.com\/an-update-of-clinical-management-of-acute-intermittent-porphyria-peer-reviewed-fulltext-article-TACG.","DOI":"10.2147\/TACG.S48605"},{"issue":"1","key":"2172_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1046\/j.1365-2796.2000.00697.x","volume":"248","author":"A Wikberg","year":"2000","unstructured":"Wikberg A, Andersson C, Lithner F. Signs of neuropathy in the lower legs and feet of patients with acute intermittent porphyria. J Intern Med. 2000;248(1):27\u201332.","journal-title":"J Intern Med"},{"key":"2172_CR11","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1159\/000330683","volume":"66","author":"HC Kuo","year":"2011","unstructured":"Kuo HC, Huang CC, Chu CC, et al. Neurological complications of acute intermittent porphyria. Eur Neurol. 2011;66:247\u201352.","journal-title":"Eur Neurol"},{"issue":"5","key":"2172_CR12","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1002\/hep.30936","volume":"71","author":"L Gouya","year":"2020","unstructured":"Gouya L, Ventura P, Balwani M, et al. EXPLORE: a prospective, multinational, natural history study of patients with acute hepatic porphyria with recurrent attacks. Hepatology. 2020;71(5):1546\u201358.","journal-title":"Hepatology"},{"key":"2172_CR13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2147\/TACG.S48605","volume":"8","author":"E Pischik","year":"2015","unstructured":"Pischik E, Kauppinen R. An update of clinical management of acute intermittent porphyria. Appl Clin Genet. 2015;8:201\u201314.","journal-title":"Appl Clin Genet"},{"issue":"30","key":"2172_CR14","first-page":"1","volume":"94","author":"AM Jim\u00e9nez-Monreal","year":"2015","unstructured":"Jim\u00e9nez-Monreal AM, Antonia Murcia M, G\u00f3mez-Murcia V, et al. Anthropometric and quality-of-life parameters in acute intermittent porphyria patients. Medicine (United States). 2015;94(30):1\u20138.","journal-title":"Medicine (United States)"},{"key":"2172_CR15","doi-asserted-by":"crossref","unstructured":"Ventura P, Bonkovsky HL, Gouya L, et al. Efficacy and safety of givosiran for acute hepatic porphyria: 24-month interim analysis of the randomized phase 3 ENVISION study. Liver Int. 2022:42(1):161\u201372.","DOI":"10.1111\/liv.15090"},{"issue":"7","key":"2172_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0235574","volume":"15","author":"AM Cohen","year":"2020","unstructured":"Cohen AM, Chamberlin S, Deloughery T, et al. Detecting rare diseases in electronic health records using machine learning and knowledge engineering: case study of acute hepatic porphyria. PLoS ONE. 2020;15(7):1\u201315. https:\/\/doi.org\/10.1371\/journal.pone.0235574.","journal-title":"PLoS ONE"},{"issue":"4","key":"2172_CR17","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1002\/hep.29313","volume":"66","author":"M Balwani","year":"2017","unstructured":"Balwani M, Wang B, Anderson KE, et al. Acute hepatic porphyrias: recommendations for evaluation and long term management. Hepatology. 2017;66(4):1314\u201322.","journal-title":"Hepatology"},{"key":"2172_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/8873219","volume":"2020","author":"GN Cerbino","year":"2020","unstructured":"Cerbino GN, Assali LA, Varela LS, et al. Acute intermittent porphyria in a man with dual enzyme deficiencies. Case Rep Genet. 2020;2020:1\u20136.","journal-title":"Case Rep Genet"},{"issue":"5","key":"2172_CR19","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s40271-018-0319-3","volume":"11","author":"A Simon","year":"2018","unstructured":"Simon A, Pompilus F, Querbes W, et al. Patient perspective on acute intermittent porphyria with frequent attacks: a disease with intermittent and chronic manifestations. Patient. 2018;11(5):527\u201337. https:\/\/doi.org\/10.1007\/s40271-018-0319-3.","journal-title":"Patient"},{"key":"2172_CR20","doi-asserted-by":"crossref","unstructured":"Naik H, Stoecker M, Sanderson SC, et al. Experiences and concerns of patients with recurrent attacks of acute hepatic porphyria: a qualitative study. Mol Genet Metab. 2016;119(3):278\u201383.","DOI":"10.1016\/j.ymgme.2016.08.006"},{"issue":"8","key":"2172_CR21","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.jval.2011.06.013","volume":"14","author":"DL Patrick","year":"2011","unstructured":"Patrick DL, Burke LB, Gwaltney CJ, et al. Content validity\u2014establishing and reporting the evidence in newly developed Patient-Reported Outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: Part II\u2014assessing respondent understanding. Value Health. 2011;14(8):978\u201388.","journal-title":"Value Health"},{"key":"2172_CR22","unstructured":"U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research; U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research; U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health. Patient reported outcome measures: use in medical product development to support labeling claims. 2009."},{"key":"2172_CR23","unstructured":"US Food and Drug Administration. Patient-focused drug development: collecting comprehensive and representative input guidance for industry, food and drug administration staff, and other stakeholders DRAFT GUIDANCE. 2018. http:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/default.htm."},{"key":"2172_CR24","unstructured":"United States Department of Health and Human Services, Food and Drug Administration. Patient-focused drug development: methods to identify what is important to patients. 2019. http:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/default.htmand\/or."},{"issue":"7","key":"2172_CR25","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.jval.2017.11.014","volume":"21","author":"DM Turner-Bowker","year":"2018","unstructured":"Turner-Bowker DM, Lamoureux RE, Stokes J, et al. Informing a priori sample size estimation in qualitative concept elicitation interview studies for clinical outcome assessment instrument development. Value Health. 2018;21(7):839\u201342. https:\/\/doi.org\/10.1016\/j.jval.2017.11.014.","journal-title":"Value Health"},{"key":"2172_CR26","first-page":"45","volume-title":"The discovery of grounded theory: strategies for qualitative research","author":"BG Glaser","year":"1967","unstructured":"Glaser BG, Strauss AL. The discovery of grounded theory. In: The discovery of grounded theory: strategies for qualitative research. New York: Aldine de Gruyter; 1967. p. 45\u201377."},{"key":"2172_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4135\/9781446221792.n3","volume-title":"Rethinking methods in psychology","author":"K Charmaz","year":"1995","unstructured":"Charmaz K, Smith J, Harr\u00e9 R, Van Langenhove L. Grounded theory. In: Rethinking methods in psychology. London: Sage; 1995. p. 27\u201349."},{"issue":"8","key":"2172_CR28","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s11136-010-9677-6","volume":"19","author":"KE Lasch","year":"2010","unstructured":"Lasch KE, Marquis P, Vigneux M, et al. PRO development: rigorous qualitative research as the crucial foundation. Qual Life Res. 2010;19(8):1087\u201396.","journal-title":"Qual Life Res"},{"issue":"3","key":"2172_CR29","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1177\/0049124113500475","volume":"42","author":"JL Campbell","year":"2013","unstructured":"Campbell JL, Quincy C, Osserman J, Pedersen OK. Coding in-depth semistructured interviews: problems of unitization and intercoder reliability and agreement. Sociol Methods Res. 2013;42(3):294\u2013320.","journal-title":"Sociol Methods Res"},{"issue":"1","key":"2172_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-021-01816-2","volume":"16","author":"L Gill","year":"2021","unstructured":"Gill L, Burrell S, Chamberlayne J, et al. Patient and caregiver experiences of living with acute hepatic porphyria in the UK: a mixed-methods study. Orphanet J Rare Dis. 2021;16(1):1\u201314. https:\/\/doi.org\/10.1186\/s13023-021-01816-2.","journal-title":"Orphanet J Rare Dis"},{"issue":"106","key":"2172_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-021-01742-3","volume":"16","author":"J Buend\u00eda-Mart\u00ednez","year":"2021","unstructured":"Buend\u00eda-Mart\u00ednez J, Barreda-S\u00e1nchez M, Rodr\u00edguez-Pe\u00f1a L, et al. Health impact of acute intermittent porphyria in latent and non-recurrent attacks patients. Orphanet J Rare Dis. 2021;16(106):1\u20138. https:\/\/doi.org\/10.1186\/s13023-021-01742-3.","journal-title":"Orphanet J Rare Dis"},{"key":"2172_CR32","unstructured":"Foundation AP, Bonkovsky H, Anderson K, Desnick R. The voice of the patient. Report of an externally-led patient-focused drug development meeting acute porphyrias. 2017. https:\/\/www.fda.gov\/media\/130386\/download."}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-022-02172-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-022-02172-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-022-02172-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T10:07:28Z","timestamp":1661335648000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-022-02172-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,30]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["2172"],"URL":"https:\/\/doi.org\/10.1007\/s12325-022-02172-8","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,30]]},"assertion":[{"value":"11 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}